ModuleMD shows AI documentation, front-desk agents and skin-test measurement for allergy EHR
ModuleMD, which makes electronic health record software for allergy and immunology practices, showed its WISE Touch AI experience at the American College of Allergy, Asthma & Immunology annual meeting in Phoenix, the company says. The release brings AI-assisted documentation, clinical decision support and CPT code suggestions into one platform.
The company says its JOSH documentation tool turns conversations into structured clinical notes in more than 75 languages, and ModuleMD Front Desk runs five agents for intake, scheduling, insurance eligibility, authorisations and referrals, coordinated by a supervisor agent. SkinSight uses images from a practice's own device to detect and measure wheal and flare reactions in allergy skin tests and send the results to the patient's chart, while ModuleMDQ lets staff query practice data in natural language. ModuleMD cites strong interest from existing clients after a first-look webinar but names no customers, deployments or accuracy figures for the AI features.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 21 Chelsea and Westminster Hospital launches multilingual AI avatar platform for lung cancer patients Nov 21 ChatGPT Health reaches Android, desktop and dots; health chats now follow the training setting Nov 20 OpenAI launches MedChemBench to test AI models on medicinal chemistry reasoning Nov 20 Danaher and Microsoft build an agentic platform for lab instruments Nov 19 Knit Health raises $35 million to roll out its healthcare world modelLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Danaher and Microsoft build an agentic platform for lab instruments
PharmaForceIQ Launches Share of Answer for Pharma AI Visibility
The Rx Assistant launches Builder, a no-code platform for pharma AI experiences
OhMD Launches Outcomes for Automated Patient Workflows
Isomorphic Labs and MSD team up to design cancer drugs with AI
Daily AI Brief: the AI news that matters, in your inbox.